Docoh
Loading...

20/20 GeneSystems

Filed: 30 Apr 19, 4:48pm
schemaVersion:

1-K: Filer Information

Issuer CIK
0001139685 
Issuer CCC
XXXXXXXX 
Is filer a shell company?Radio button not checked Yes Radio button checked No
Is the electronic copy of an official filing submitted in paper format?Checkbox not checked
File Number
 
Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination?Radio button not checked Yes Radio button checked No
Successor File Number
 

Submission Contact Information

Is this a LIVE or TEST Filing?Radio button checked LIVE Radio button not checked TEST
Would you like a Return Copy?Checkbox not checked
Period
12-31-2018 
Name
 
Phone
 
E-Mail Address
 
Notify via Filing Website only?Checkbox not checked

1-K: Tab 1 Notification

This Form 1-K is to provide anRadio button checked Annual Report Radio button not checked Special Financial Report for the fiscal year
Fiscal Year End

12-31-2018 

Exact name of issuer as specified in the issuer's charter

20/20 GeneSystems, Inc. 

CIK

0001139685 

Jurisdiction of Incorporation / Organization

DELAWARE  

I.R.S. Employer Identification Number

52-2272107 

Address of Principal Executive Offices

Address 1

9430 Key West Ave. 

Address 2

 

City

Rockville 

State/Country

MARYLAND  

Mailing Zip/ Postal Code

20850 

Phone

240-453-6339 

Title of each class of securities issued pursuant to Regulation A

Series B Preferred Stock 

1-K: Summary Information Regarding Prior Offering and Proceeds

Summary Information

Checkbox not checkedThe following information must be provided for any Regulation A offering that has terminated or completed prior to the filing of this Form 1-K, unless such information has been previously reported in a manner permissible under Rule 257. If such information has been previously reported, check this box and leave the rest of Part I blank.

Commission File Number of the offering statement

024-10816 

Date of qualification of the offering statement

08-17-2018 

Date of commencement of the offering

08-17-2018 

Amount of securities qualified to be sold in the offering

3399433 

Amount of securities sold in the offering

1398995 

Price per security

$ 3.5300 

The portion of aggregate sales attributable to securities sold on behalf of the issuer

$ 12000000.00 

The portion of the aggregate sales attributable to securities sold on behalf of selling securityholders

$ 0.00 

Fees in connection with this offering and names of service providers.

Underwriters - Name of Service Provider
SI SECURITIES, LLC
Underwriters - Fees
$ 900000.00 
Sales Commissions - Name of Service ProviderSales Commissions - Fee
$  
Finders' Fees - Name of Service ProviderFinders' Fees - Fees
$  
Accounting or Audit - Name of Service Provider
DBBMCKENNON
Accounting or Audit - Fees
$ 56000.00 
Legal - Name of Service Provider
BEVILACQUA PLLC
Legal - Fees
$ 65000.00 
Promoters - Name of Service ProviderPromoters - Fees
$  
Blue Sky Compliance - Name of Service ProviderBlue Sky Compliance - Fees
$  
CRD Number of any broker or dealer listed

170937 

Net proceeds to the issuer

$ 4510419.00 

Clarification of responses (if necessary)